Human medicines European public assessment report (EPAR): Pixuvri, pixantrone dimaleate, Lymphoma, Non-Hodgkin, Date of authorisation: 10/05/2012, Revision: 19, Status: Authorised
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf.
"Human medicines European public assessment report (EPAR): Pixuvri, pixantrone dimaleate, Lymphoma, Non-Hodgkin, Date of authorisation: 10/05/2012, Revision: 19, Status: Authorised." Case Medical Research (2019)